# Breathe Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/breathe-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.breathetechnologies.com
- Total disclosed funding: $49M
- Latest round: Series A (Jun 19, 2014)
- Investors on record: 6

## About

Breathe Technologies, Inc. specializes in innovative respiratory solutions aimed at enhancing patient care and improving quality of life. The company develops advanced technologies to support individuals with respiratory challenges.Founded in 2005 and headquartered in Irvine, US, Breathe Technologies, Inc. focuses on innovative respiratory solutions. The firm has undergone various strategic developments to enhance its offerings. It was co-founded by industry veterans with a commitment to advancing respiratory care. As of March 2017, the company raised USD 12.75 mn in funding, bringing the total amount raised to USD 12.75 mn. The firm has successfully completed five deals since its inception.Breathe Technologies provides a range of advanced respiratory products designed to enhance the quality of life for patients with respiratory issues. Their offerings include innovative devices for improved breathing support and personalized care solutions, which are utilized by healthcare providers to manage various respiratory conditions.The revenue for Breathe Technologies is generated primarily through partnerships and direct sales of its innovative respiratory products. Clients include healthcare providers who integrate Breathe Technologies' solutions into their patient care practices, ensuring personalized and effective support for respiratory health.Looking ahead, Breathe Technologies aims to launch new respiratory products designed to enhance treatment options for patients by 2025. The company is also targeting expansion into European and Asian markets, focusing on establishing a presence in key healthcare sectors to increase accessibility to their innovative solutions. The funding raised in March 2017 will support these initiatives, allowing for research and development of new products as well as marketing efforts to penetrate these new geographic regions.

## Funding rounds

- Series A, Jun 19, 2014, $7.2M — Kleiner Perkins
- Series C, May 18, 2010, $23M — Delphi Ventures, Kleiner Perkins, DAG Ventures, Johnson & Johnson Innovation
- Series B, Mar 26, 2008, $15M — Delphi Ventures, Kleiner Perkins, Synergy Capital, Life Science Angels, Inc.
- Series A, Mar 31, 2006, $4M — Delphi Ventures, Synergy Capital

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series B, Series C
- Synergy Capital — Series A, Series B
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B, Series C, Series A
- Life Science Angels, Inc. — Series B
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C